Affiliations: [a] CHDI Management/CHDI Foundation, Princeton, NJ, USA
| [b] Bridlewood Consulting LLC, Flower Mound, TX, USA
| [c] Rancho Biosciences LLC, San Diego, CA, USA
| [d]
Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA
Correspondence:
[*]
Correspondence to: Jeff Aaronson, CHDI Management/CHDI Foundation, 155 Village Boulevard, Suite 200, Princeton, NJ 08540, USA. Tel.: +1 609 945 9616; E-mail: Jeff.Aaronson@chdifoundation.org.
Note: [1] Present address: Insilico Medicine Hong Kong Limited, Pak Shek Kok, Hong Kong
Note: [2] Present address: Naason Science Inc., KBIO New Drug Development Center, Osong-eup, Cheongju-si, Korea
Abstract: HDinHD (Huntington’s Disease in High Definition; HDinHD.org) is an open online portal for the HD research community that presents a synthesized view of HD-related scientific data. Here, we present a broad overview of HDinHD and highlight the newly launched HDinHD Explorer tool that enables researchers to discover and explore a wide range of diverse yet interconnected HD-related data. We demonstrate the utility of HDinHD Explorer through data mining of a single collection of newly released in vivo therapeutic intervention study reports alongside previously published reports.
Keywords: HDinHD, Huntington’s disease in high definition, data dissemination, rolipram